🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The OncoAlert 🚨Newsletter NOW OUT Covering July 5-11. 2024 REGISTER at Oncoalert360.com or oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: ✅UNICANCER-PRODIGE23🧪 in #RectalCancer ✅Renal function after SABR in 1ry #KidneyCancer Vivian Tan MD Alex Louie MD, PhD Rohann Correa

Had the pleasure of mentoring a medical student in publishing a case report through the Schulich WesternU ORIoN (#Oncology #Research #Internship) program! Congratulations Josh! 📝

"Impact of the #COVID19 Pandemic on Academic Productivity in Oncology," authored by ACRO member Vivian Tan MD and colleagues Drs. Andrew Warner, Anthony Nichols, Eric Winquist, and David Palma, is now published on #CURiE: cureus.com/articles/27110…

#kidney #SABR takes center stage at the presidential symposium at #ASTRO2024 Shankar Siva ✅ Optimal dose regimen ✅ Role of post-treatment kidney biopsy ✅ SABR in the solitary kidney ✅ Optimal post-treatment follow-up 👏 #SABR for RCC ready for prime time

👤 NRG-HN005 presented during plenary at #ASTRO2024 #radonc Sue Yom 1️⃣ Arm 1: 70 Gy + cisplatin - PFS 98.1% 2️⃣ Arm 2: 60 Gy + cisplatin - PFS 88.6% 3️⃣ Arm 3: 60 Gy + nivolamab - PFS 90.3% ➡️ SOC remains 70 Gy + cisplatin

Presented 🚀 MISSILE 🚀 at #ASTRO2024 Combined ☢️ #SABR and 🔪 #surgery in early 🫁 #NSCLC was safe with reasonable clinical outcomes, but similar to surgery alone 🚨 Publication in RED journal here authors.elsevier.com/sd/article/S03… @drdavidpalma Alex Louie MD, PhD Rohann Correa Tim Nguyen

Dicussant Cliff Robinson reviews the MISSILE study presented by Vivian Tan MD at @ASTRO24 ➡️makes the point that the incomplete pathological complete response points to the need for better adjuvant therapy 🚨However some studies of adjuvant IO post #SABR not fairing so well

This new #RedJournal article from Tan et al was presented recently at #ASTRO24 during the Scientific Session 32. Read their article on measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage NSCLC here: tinyurl.com/tanam24

We ❤️ ASTRO! Thanks to everyone for yet another annual conference in the books! We had so much fun at #ASTRO24 and at the debut of our #minimicinterviews! Here is Vivian Tan MD discussing the outcomes of the MISSILE early-stage lung trial!

Incredible experience at #ASTRO2024 in Washington DC 🏛️! Grateful for the opportunity to explore the latest advancements in #radonc and for all the new connections made. Leaving inspired and energized! 💪 Looking forward to the next!

'Music is good for the soul': A holiday concert warms spirits inside the Verspeeten Family Cancer Centre london.ctvnews.ca/music-is-good-…

ORIoN Oncology Research Internship pairs Schulich WesternU medical students with resident mentors in writing an #oncology case report 📝 Congratulations to all of our students who presented at ORIoN Research Night ⭐️ #MedEd #radonc #medonc #heme #research London Health Sciences Centre

Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney by Vivian Tan MD, Rohann Correa et al buff.ly/3ZLN99L #UroSoMe #MedTwitter #EUO #RenalCellCarcinoma

Exciting discussions on imaging and radioligand therapies at PSMA and Beyond PSMA and Beyond Conference including upcoming trials of PSMA RLT in combo with SABR ☢️ #radiationoncology #prostatecancer #PSMAandBeyond2025